Home Newsfeeds Citigroup Maintains Buy on DraftKings, Lowers Price Target to $20

Citigroup Maintains Buy on DraftKings, Lowers Price Target to $20

Citigroup analyst Jason Bazinet maintains DraftKings (NASDAQ:DKNG) with a Buy and lowers the price target from $26 to $20.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Citigroup analyst Jason Bazinet maintains DraftKings (NASDAQ:DKNG) with a Buy and lowers the price target from $26 to $20.

Alnylam Shares Detailed Patisiran Data From Rare Disease Study

By Vandana Singh

September 8, 10:21 AM

Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) announced positive results from the APOLLO-B Phase 3 study of patisiran for transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.

ALNY

The Equal-Weighted S&P 500 Rallied From 52-Week Lows To 52-Week Highs In A Month

By Erica Kollmann

December 19, 6:09 PM

The S&P 500 Index is up more than 5% over the past month. On an equal-weighted basis, the move is even more impressive. What Happened:

RSP

News

RF Acquisition Corp. Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

By Benzinga Newsdesk

June 15, 4:21 PM

RF Acquisition Corp. (NASDAQ:RFACU, RFAC, RFACW, RFACR)))) (the "Company") announced today that it received a written notification (the "Notice") from the Nasdaq Stock Market LLC ("Nasdaq") dated June 9, 2023,

RFAC